Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (139K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Matsukawa, T.
Right arrow Articles by Ohba, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsukawa, T.
Right arrow Articles by Ohba, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Oxford University Press 2635-2639

Analysis of chromatin structure of rat [alpha]1-acid glycoprotein gene; changes in DNase I hypersensitive sites after thyroid hormone, glucocorticoid hormone and turpentine oil treatment

Analysis of chromatin structure of rat [alpha] 1 -acid glycoprotein gene; changes in DNase I hypersensitive sites after thyroid hormone, glucocorticoid hormone and turpentine oil treatment Toru Matsukawa, Hiroki Kawasaki, Makoto Tanaka and Yoshiki Ohba*

Faculty of Pharmaceutical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920, Japan

Received March 7, 1997; Revised and Accepted May 6, 1997

ABSTRACT

Transcription of the rat [alpha]1-acid glycoprotein (AGP) gene is activated by glucocorticoid, thyroid hormone (T3) and cytokines. Following these treatments, the chromatin structure of this gene was analyzed by means of digestion with DNase I or micrococcal nuclease. Four DNase I hypersensitive sites were observed in the 5'-upstream region of the rat AGP gene of liver cells. They were designated HS1, HS2, HS3 and HS4 (3' -> 5'). After T3 treatment the sensitivity of HS1 and HS2 increased and after dexamethasone (Dex) treatment that of all four sites did so. Three new sites appeared after turpentine oil treatment, while the sensitivities of HS3 and HS4 increased. We conclude that transcriptional activation of the gene by T3 and Dex have very similar mechanisms, but that at the inflammation stage they become slightly different. The increase in sensitivity at HS1 and HS2 after T3 treatment in vivo was successfully reproduced in a cell-free system by in vitro treatment with T3. HS1, HS2 and HS3 were also sensitive for micrococcal nuclease.

INTRODUCTION

The rat [alpha]1-acid glycoprotein (AGP) gene is a single copy gene (1 ) and one of the acute phase protein genes which is expressed in liver cells in the acute phase response (2 ,3 ). Cytokines such as IL-1 and IL-6 activate synthesis of AGP (4 ,5 ). Glucocorticoids also induce AGP (4 ,5 ) and we found that expression of the rat AGP gene was also controlled by thyroid hormone [3,3',5-L-triiodothyronine (T3)] (6 ). The glucocorticoid response element (GRE) of the rat AGP gene is localized in the 5'-upstream region of the gene (7 ) and a thyroid hormone response element (TRE) has been identified in the first intron (6 ). It still remains unclear, however, how ligand-receptor complexes activate mRNA synthesis. Steroid hormone receptors have been shown to interact in vitro directly with components of the initiation complex, but the physiological significance of these interactions also remains unclear (8 ). Finally, there have been indications of the existence of co-activators that act as bridging factors between steroid hormone receptors and the transcription initiation complex (9 ), but the character of these co-activators is not yet well understood.

Chromatin structure plays an important role in regulating gene expression (10 -12 ) and the DNase I hypersensitivity assay is the most common method to analyze the structures of chromatin. DNase I hypersensitive sites (HS) are fundamental biological elements as they are ubiquitous among eukaryotes and can be divided into many classes which differ in form and function. Furthermore, many HSs have been mapped at a number of specific positions for known functions, including promoters, upstream activation sequences and enhancers of inducible genes (13 ,14 ). The acute phase protein genes are controlled by many factors, as mentioned above, but the chromatin structures of these genes have not been thoroughly investigated. We used the rat AGP gene as a model system to study changes in chromatin structure after treatment with these factors.

MATERIALS AND METHODS

Materials

Wister male rats were purchased from Sankyo Laboratory Service Co. (Toyama, Japan). DNase I and micrococcal nuclease were provided by Worthington Biochemical (Freehold, NJ). HindIII, BamHI, RNase A and proteinase K were purchased from Toyobo Co. Ltd (Tokyo, Japan) or Takara Shuzo Co. Ltd (Ohtsu, Japan) and [[alpha]-32P]dCTP from DuPont/NEN Research Products (Boston, MA). All other chemicals were obtained from Wako Pure Chemical Corp. (Osaka, Japan) or Nacalai Tesque Inc. (Kyoto, Japan).

Removal of thyroid and adrenal glands from rats and hormone treatment

Thyroids or adrenal glands were removed from 4-week-old Wister rats, who were then fed for 7 days to let them recover. Their diet was supplemented with either 1% lactate calcium or 0.5% NaCl solution. T3 (2 mg/kg body wt) was injected into rats i.p. as described (6 ). A synthesized glucocorticoid, dexamethasone (Dex), was dissolved in ethanol and then mixed with an equal volume of water. Dex (2 mg/kg body wt) was injected i.p. and livers were removed from rats 12 h after injection. Turpentine oil (2 ml/kg body wt) was injected under the back skin of the rats.

Digestion and purification of DNA

Liver and spleen nuclei were prepared from ~6-week-old rats as described previously (6 ). For DNase I digestion, purified nuclei were suspended in 60 mM KCl, 15 mM NaCl, 15 mM Tris-HCl, pH 7.5, 6 mM MgCl2, 0.05 mM CaCl2, 10% glycerol, 0.5 mM DTT at a concentration of 108 nuclei/ml and incubated on ice for 10 min with or without DNase I. Alternatively, the nuclei were digested with micrococcal nuclease as described elsewhere (15 ), with some modifications, i.e. 1 mM PMSF, 1 mM DTT and 0.1 mM EDTA were added to the digestion buffer and the nuclei were incubated for 5 min. After addition of 10 mM EDTA, the nuclei were centrifuged and suspended in TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA), to which were added 1% SDS, 100 mM NaCl, 5 mM EDTA and 0.3 mg/ml proteinase K, followed by incubation at 37oC for 12 h. Proteins were removed by successive treatments with phenol, phenol/chloroform (1:1) and chloroform/isoamyl alcohol (24:1), all accompanied by gentle mixing and each treatment repeated twice. After precipitation with ethanol, the DNA was dissolved in TE to which 100 [mu]g/ml RNase A and 200 U HindIII or BamHI were added. The solution was then incubated at 37oC for 3 h. Proteins were removed again as described above and purified DNA obtained. This purified DNA (100 [mu]g) was further treated with 200 U HindIII or BamHI and, after the protein had been removed as described above, DNA samples for gel electrophoresis were obtained.

Incubation of nuclei with T3

Liver nuclei from 6-week-old rats were purified as described above, washed in 0.25 M sucrose, 20 mM Tris-HCl, pH 7.8, 1.1 mM MgCl2, 1 mM PMSF and 1 mM DTT and suspended in the same buffer at a concentration of 108 nuclei/ml, to which was added 10-12 or 10-10 M T3 or solvent. The nuclei were incubated for 30 min at 20oC.

Probe labeling and Southern blotting

BamHI (at +381 bases from one of the transcription initiation sites; 16 )-HindIII (+952) and PstI (-64)-BamHI (+381) fragments of the rat AGP gene were labeled with [[alpha]-32P]dCTP using the Multiprime DNA labeling system (Amersham, Little Chalfont, UK) and used as probes.

Southern blot analysis was performed by the method described by Sambrook et al. (17 ) with some modifications. DNA (20 [mu]g/lane) digested by either DNase I or micrococcal nuclease was electrophoresed respectively on a 1 or 1.5% agarose gel (14 * 13 cm) in 40 mM Tris-acetate, 1 mM EDTA at 60 V for ~6 h, then blotted onto a BA85 nitrocellulose filter (Schleicher & Schuell, Dassel, Germany) by means of overnight capillary transfer and indirectly end-labeled by hybridization with a 32P-labeled probe at 42oC for 16 h. The filters were washed twice with 0.2* SSC at 65oC for 30 min.

RESULTS

Changes in DNase I hypersensitive sites of the rat AGP gene induced after T3 injection

Soon after removal of the thyroid or adrenal glands, AGP mRNA and protein levels increased rapidly, then declined gradually. Five days after removal of the adrenal or the thyroid glands the mRNA level had decreased to half or an eighth respectively that of normal rats and these low levels were maintained for some time (data not shown). T3 or Dex was injected 7 days after removal of the glands.

In order to analyze HSs formed on the rat AGP chromatin by T3 treatment, nuclei were isolated from the liver 5 h after T3 injection. The isolated nuclei were then treated with DNase I, after which the DNA was isolated and treated with HindIII. Following electrophoresis, the DNA fragments were hybridized with a 32P-labeled probe consisting of a BamHI-HindIII fragment. As shown in Figure 1 , on incubation with 8 U/ml DNase I (lanes 5 and 6) five radioactive bands were detected consisting of 1.1, 1.3, 3.1, 6.6 and 17 kb fragments, where the 17 kb fragment was a HindIII-HindIII fragment and the others were DNase I accessible sites and designated HS1, HS2, HS3 and HS4 respectively. HS1 was located at ~0.2 kb, HS2 at 0.4 kb, HS3 at 2.2 kb and HS4 at 5.7 kb upstream from one of the transcription initiation sites of the rat AGP gene (16 ; lower panel in Fig. 1 ). These sites could still be detected on the chromatin derived from thyroidectomized and non-T3-treated rats, while the intensity of the bands was enhanced, especially on HS1 and HS2, after treatment with T3. When the enzyme was reduced to 4 U (lanes 3 and 4), only HS3 and HS4 could be detected, indicating that these two sites were more sensitive to DNase I than HS1 and HS2. It should be noted that no detectable band was observed at the TRE site.


Figure 1. DNase I hypersensitive sites after T3 treatment of thyroidectomized rats. Livers (lanes 1-6) or spleens (lanes 7-10) were removed from thyroidectomized rats 5 h after injection of T3 (lanes 1, 3, 5, 7 and 9) or of solvent only (lanes 2, 4, 6, 8 and 10). Nuclei were incubated with 4 (lanes 3 and 4), 8 (lanes 5 and 6) or 15 U/ml DNase I (lanes 9 and 10) or without DNase I (lanes 1, 2, 7 and 8). Purified DNA was digested completely with HindIII. The numbers in kb on the left side of the gel show the lengths of the bands. These were designated HS1, HS2, HS3 and HS4 as shown on the right side of the gel. The lower panel shows a schematic drawing of the positions of the HSs. Numbers indicate the length in kilobases from one of the transcription initiation sites. Hatched boxes, exons of the rat AGP gene; black box, TRE; dotted box, GRE; white box, BamHI-HindIII fragment used as a probe.

Spleen nuclei derived from the same rats from which the liver was excised to analyze the HS were digested with 4, 8 or 15 U/ml DNase I. No HS was detected in any of the samples, even when the concentration of DNase I was increased to 15 U/ml, but faint smears were seen at the higher molecular weight section of the gel (lanes 9 and 10, only lanes digested with 15 U/ml DNase I are shown). However, normal ladder patterns were revealed by ethidium bromide staining (data not shown). The AGP chromatin of the spleen nuclei was much more insensitive to DNase I than that of liver nuclei. As AGP is synthesized in the liver of normal rats and these HSs appeared in the rat AGP gene of liver chromatin, the formation of HSs seems to be necessary for expression of the rat AGP gene to occur.

The hyperthyroid state was obtained by daily administration of T3 to normal rats for 6 days. Induction of AGP mRNA did not increase, but this level was maintained more than twice as long as that after a single administration of T3 and the AGP level in blood after 6 days had increased to four times that of normal rats and double that observed after a single shot of T3 (data not shown). The effect of T3 on formation of HSs was further examined in such hyperthyroid rats. In addition to HS1 and HS2, the sensitivities of HS3 and HS4 also increased (Fig. 2 , lanes 2-5), so that all four sites were more accessible to DNase I in these rats. Constant stimuli induced change(s) in the HS3 and HS4 regions as well as in HS1 and HS2.


Figure 2. DNase I hypersensitive sites of liver nuclei of hyperthyroid rats. T3 was injected into rats once per day for a week. Livers were removed 5 h after the final T3 injection. Nuclei from hyperthyroid rats (lanes 2, 4 and 6) or normal rats (lanes 1, 3, 5 and 7) were digested with 4 (lanes 2 and 3), 8 (lanes 4 and 5) or 15 U/ml DNase I (lanes 6 and 7) or without DNase I (lane 1). See the lower panel of Figure 1 for a schematic drawing of the positions of HSs.

Changes in DNase I hypersensitive sites of the rat AGP gene induced after Dex injection

Very faint bands were observedinchromatin prepared from adrenalectomized rats (Fig. 3 ). After Dex was injected into rats, four HSs were always found at the same positions and both the HS3 and HS4 bands were as much enhanced as HS1 and HS2. Furthermore, HS3 and HS4 were more sensitive to DNase I than HS1 and HS2. Although HS1 was Dex inducible, it was somewhat faint and less sensitive than HS2 in comparison with the results shown in Figure 1 . This reduced sensitivity of HS1 may be a direct result of glucocorticoid receptor binding to the GRE (-121 to -107) of the rat AGP gene (7 ), located just beside HS1, or of the binding of other transcription factors which interact with the receptor (18 ,19 ). The GRE site itself was insensitive to DNase I, regardless of Dex treatment.


Figure 3. DNase I hypersensitive sites after Dex treatment of adrenalectomized rats. Livers were removed from adrenalectomized rats 12 h after Dex (lanes 1, 3, 5 and 7) or solvent (lanes 2, 4, 6 and 8) injection. Nuclei were digested with 4 (lanes 3 and 4), 10 (lanes 5 and 6) or 15 U/ml DNase I (lanes 7 and 8) or without DNase I (lanes 1 and 2). See the lower panel of Figure 1 for a schematic drawing of the positions of HSs.

Induction of unique bands after turpentine oil treatment

As mentioned earlier, a series of acute phase proteins, including AGP, are induced during inflammation, which can be realized by administration of turpentine oil in vivo to produce experimental inflammation. Turpentine oil was injected s.c. into normal rats and after 12 h the HS pattern was analyzed on rat AGP liver chromatin.

As shown in Figure 4 , four HS bands were always found on the chromatin of rats not treated with turpentine oil, but three unique bands were detected as a result of turpentine oil treatment. One was located at 6.0 kb and the other at 2.3 kb, which correspond to 5.1 kb and 1.4 kb from the cap. These two sites were designated THS1 and THS2. The last one, marked HS1', was smeared and located on the 3'-side of HS1 and overlapped with the GRE. We could not determine whether HS1 had actually disappeared and a new HS1' had emerged or whether the position of HS1 had simply shifted to that of HS1'. Moreover, the intensity of HS3 increased a little and that of HS4 very much due to turpentine oil treatment. Finally, the order of band intensity became HS4 > THS2 > HS3 > HS2 > HS1' > THS1.


Figure 4. DNase I hypersensitive sites after turpentine oil treatment. Livers were removed from normal rats 12 h after turpentine oil injection. Nuclei from normal rats (lanes 2, 4, 6 and 8) and turpentine oil-treated rats (lanes 1, 3, 5 and 7) were digested with 4 (lanes 3 and 4), 8 (lanes 5 and 6) or 15 U/ml DNase I (lanes 7 and 8) or without DNase I (lanes 1 and 2). THS1 and THS2 were identified as turpentine oil-specific HSs and HS1 was found to have shifted to HS1'. Other HSs were as described in the legend to Figure 1. The lower panel shows a schematic drawing of the positions of the HSs. Please refer to Figure 1 for an explanation of the symbols.

Induction of increased sensitivity at HSs by T3 treatment in vitro

Isolated nuclei prepared from normal rats were incubated with 10-12 or 10-10 M T3 or with solvent at 20oC for 30 min, then treated with DNase I (Fig. 5 ). Since DNA was to some extent digested by endogenous nuclease(s) during the incubation period (lane 1), a smeared background appeared in all lanes. HS4 could not be clearly observed after DNase I digestion because of such a background, but HS1, HS2 and HS3 could (lanes 2-4). The sensitivity of HS3 did not change during the treatments, but whereas that of HS1 and HS2 remained more or less the same after the 10-12 M T3 treatment, it roughly doubled after the 10-10 M treatment. These results were identical to those obtained in vivo (Fig. 1 ). Changes in chromatin structure were produced successfully within 30 min after treatment of nuclei with T3 in vitro. This report is therefore the first concerning induction of HSs in vitro following treatment of nuclei with a hormone in a cell-free system.

Micrococcal nuclease digestion of the rat AGP chromatin

Finally, nuclei were digested with micrococcal nuclease in order to examine whether these HSs were also sensitive to the nuclease and whether their sensitivity changed after T3 treatment. Nuclei isolated from rat liver 5 h after T3 administration were treated with various amounts of micrococcal nuclease for 5 min at 37oC. Isolated DNA was treated with BamHI, electrophoresed and hybridized with a 445 bp PstI-BamHI fragment probe. As shown in Figure 6 , a ladder pattern was observed and the bands became broader after the nuclei were treated with more micrococcal nuclease. These DNA fragments were 0.36, 0.58, 0.76, 1.2, 1.4, 1.7, 2.6 and 7.0 kb in length, which correspond to +0.02, -0.20, -0.38, -0.77, -1.1, -1.4, -2.2 and -6.6 kb respectively from the cap. This pattern was irregularly spaced and different from the normal nucleosomal pattern, which was observed on the same gel after ethidium bromide staining and before transfer (data not shown). T3 treatment did not result in any changes in the band pattern. The 7.0 kb band observed at the top represents the BamHI-BamHI fragment and the 0.58, 0.76 and 2.6 kb bands correspond to the positions of HS1, HS2 and HS3 respectively. HS1, HS2 and HS3 were also micrococcal nuclease sensitive, but the sensitivities of these sites did not increase after T3 treatment. The other sites were designated A, B, C and D as indicated in the figure. Most bands were smeared and had spread to the lower region of the gel (lanes 3 and 4); the smeared parts are marked as arches in the lower panel of the figure. None of the sites showed any increase in sensitivity after T3 treatment.


Figure 5. DNase I hypersensitive sites induced after in vitro T3 treatment. Nuclei were incubated with 10-12 (lane 3) or 10-10 M T3 (lane 4) or solvent only (lanes 1 and 2) for 30 min and then incubated with (lanes 2-4) or without (lane 1) DNase I. HS4 (arrowhead) was unclear because of a smeared background. See the lower panel of Figure 1 for a schematic drawing of the position of the HSs.



Figure 6. Micrococcal nuclease-sensitive sites of the rat AGP gene chromatin. Livers were removed from T3-treated rats (lanes 1, 3 and 5) or control rats (lanes 2, 4 and 6). Isolated nuclei were treated with 3 (lanes 1 and 2), 10 (lanes 3 and 4) or 30 U/ml micrococcal nuclease (lanes 5 and 6), while purified DNAs were digested with BamHI. The lower panel shows a schematic drawing of the positions of the digestion sites. The probe used was a PstI-BamHI fragment. Thinner arrows, weaker sites; thicker arrows, stronger sites; arches between arrows, smears on autoradiogram which proved to be sensitive to the nuclease. For an explanation of the other symbols please refer to Figure 1.

DISCUSSION

In the rat AGP gene of control liver nuclei four HSs, HS1, HS2, HS3 and HS4, were observed and these HSs were identified in all the experiments performed. Because no clear band was observed in spleen nuclei (Fig. 1 ), it was concluded that all HSs were tissue-specific hypersensitive sites. Furthermore, because the sensitivities of the four sites were very low in chromatin prepared from adrenalectomized rats (Fig. 3 ), where the amount of rat AGP mRNA declined to an eighth of that of normal rats (data not shown), formation of these HSs seemed to be necessary for expression of the gene. All sites were inducible and no constitutive sites (13 ) were found in rat AGP chromatin.

The HS patterns after T3 or Dex treatment remained more or less the same (Figs 1 -3 ). All four bands were observed and the sensitivities of HS1 and HS2 always increased. Furthermore, in hyperthyroid rats the sensitivities of HS3 and HS4 increased as much as they did after Dex treatment. These results suggest that the regulation mechanisms induced by T3 and Dex are very similar. Although the receptors and their hormone response elements were different, the hormones produced almost the same changes in chromatin structure. It was noted that the TRE and GRE sites were insensitive to DNase I, regardless of hormone treatments and this suggests that no detectable change occurred at either site.

In addition to the four bands, three new HSs, THS1, THS2 and HS1', were observed after turpentine oil treatment. Furthermore, the sensitivity of HS4 greatly increased, but that of HS2 did not change (Fig. 4 ). These results suggest that the activation mechanism induced by inflammation is different from that induced by T3 and Dex. Among the turpentine oil-specific sites, THS2 and HS1' were located near the previously reported binding sites of inflammation-specific transcription factors. THS2 was close to a cis-element, from -5300 to -5150 bp, known as the IL-6 response element (20 ). Several proteins (21 ) and a transcription factor, NFIL-6 (22 ), bind to this region. HS1' was located near the NFIL-6 binding site (-118 to -68 bp) (23 ). In the mouse albumin gene NFIL-6 reportedly binds to the distal HS region of the gene (24 ). It is thus likely that inflammation-specific transcription factors were involved in formation of the turpentine oil-specific HSs.

HS1, HS2 and HS3 were also sensitive to micrococcal nuclease (Fig. 6 ). This indicates that they are located at the linker regions of nucleosomes or at gaps in the nucleosome structure. This finding agrees with that of previous reports (14 ). Because neither the sensitivity nor the location of the HS1 and HS2 regions for micrococcal nuclease changed after T3 treatment, it can be assumed that neither movement nor displacement of nucleosomes in these regions occurred during transcriptional activation by T3.

After purified nuclei were treated with T3, HSs were induced within 30 min at the same positions as observed in vivo (Fig. 5 ). Since the physiological T3 concentration, 10-10 M, was high enough to induce the changes of chromatin structure, this result indicates that de novo protein synthesis was not required for induction of HSs. As discussed above, since no changes were observed in nucleosome arrays in the HS regions it is likely that association, dissociation and/or modification of a transcription factor(s) cause a change(s) in the chromatin structure at HS1 and HS2 and that they play a role in induction of AGP. Several transcription factors have been reported to bind to regions near HS1 [-125 to -65 bp (25 ) and-180 to -120 bp (26 )]. We also identified several protein binding sites in a region near HS2 (unpublished observations), so that these binding proteins must be related to formation of HS1 and HS2 and to stimulation of transcription. With the in vitro system described here the molecular mechanism of induction after hormone treatment can be investigated in detail.

ACKNOWLEDGEMENTS

This work was supported by Grants-in-Aid for Science Research (C) from the Ministry of Education, Science, Sports and Culture of Japan to T.M. and Y.O.

REFERENCES

1 Liao,Y.-C.J., Taylor,J.M., Vannice,G.A., Clawson,G.A. and Smuckler,E.A. (1985) Mol. Cell. Biol., 5, 3634-3639.

2 Arnaud,P., Miribel,L. and Roux,A.F. (1988) Methods Enzymol., 163, 418-430. MEDLINE Abstract

3 Eap,C.P. and Baumann,P. (1993) In Mackiewicz et al. (eds), Acute Phase Proteins. CRC Press, Boca Raton, FL, pp.107-116.

4 Heinrich,P.C., Castell,J.V. and Andus,T. (1990) Biochem. J., 265, 621-636. MEDLINE Abstract

5 Baumann,H., Prowse,K.R., Won,K.-A. and Marinkovic-Pajovic,S. (1993) In Mackiewicz et al. (eds), Acute Phase Proteins. CRC Press, Boca Raton, FL, pp.409-424.

6 Matsukawa,T., Kitagawa,M., Katayama,K., Nagai,Y., Hayashi,T., Yasuda,H. and Ohba,Y. (1996) J. Biochem., 119, 934-939. MEDLINE Abstract

7 Klein,E.S., DiLorenzo,D., Posseckert,G., Beato,M. and Ringold,G.M. (1988), Mol. Endocrinol., 2, 1343-1351. MEDLINE Abstract

8 Tsai,M.-J. and O'Malley,B.W. (1994) Annu. Rev. Biochem., 63, 451-486.

9 Beato,M., Herrlich,P. and Schütz,G. (1995) Cell, 83, 851-857. MEDLINE Abstract

10 Kornberg,R.D. and Lorch,Y. (1991) Cell, 67, 833-836. MEDLINE Abstract

11 Felsenfeld,G. (1992) Nature, 355, 219-224. MEDLINE Abstract

12 Hansen,J.C. and Ausio,J. (1992) Trends Biochem. Sci., 17, 187-191. MEDLINE Abstract

13 Gross,D.S. and Garrard,W.T. (1988) Annu. Rev. Biochem., 57, 159-197. MEDLINE Abstract

14 Elgin,S.C.R. (1988) J. Biol. Chem., 263, 19259-19262.

15 Noll,M., Thomas,J.O. and Kornberg,R.D. (1975) Science, 187, 1203-1206.

16 Reinke,R. and Feigelson,P. (1985) J. Biol. Chem., 260, 4397-4403. MEDLINE Abstract

17 Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

18 Chang,C.-J., Chen,T.-T., Lei,H.-Y., Chen,D.-S. and Lee,S.-C. (1990) Mol. Cell. Biol., 10, 6642-6653.

19 Williams,P.M., Ratajczak,T., Lee,S.C. and Ringold,G.M. (1991) Mol. Cell. Biol., 11, 4959-4965.

20 Prowse,K.R. and Baumann,H. (1988) Mol. Cell. Biol., 8, 42-51. MEDLINE Abstract

21 Won,K.-A. and Baumann,H. (1990) Mol. Cell. Biol., 10, 3965-3978.

22 Akira,S., Isshiki,H., Sugita,T., Tanabe,O., Kinoshita,S., Nishio,Y., Nakajima,T., Hirano,T. and Kishimoto,T., (1990) EMBO J., 9, 1897-1906. MEDLINE Abstract

23 Nishio,Y., Isshiki,H., Kishimoto,T. and Akira,S. (1993) Mol. Cell. Biol., 13, 1854-1862. MEDLINE Abstract

24 Liu,J.-K., Bergman,Y. and Zaret,K.S. (1988) Genes Dev., 2, 528-541.

25 Ratajczak,T., Williams,P.M., DiLorenzo,D. and Ringold,G.M. (1992) J. Biol. Chem., 267, 11111-11119. MEDLINE Abstract

26 Ingrassia,R., Savoldi,G.F., Caraffini,A., Tironi,M., Poiesi,C., Williams,P., Albertini,A. and Di Lorenzo,D.. (1994) DNA Cell Biol., 13, 615-627. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +81 76 234 4480; Fax: +81 76 234 4480; Email: ohba@kenroku.ipc.kanazawa-u.ac.jp
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
L. I. McKay and J. A. Cidlowski
Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways
Endocr. Rev., August 1, 1999; 20(4): 435 - 459.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (139K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Matsukawa, T.
Right arrow Articles by Ohba, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsukawa, T.
Right arrow Articles by Ohba, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?